Showing results (1-10 of 268) with videos related to

Sort By:
Pageof 27
Zeitschrift Fur Rheumatologie|May 30, 2024
[The German COVID-19 rheumatism register]Rebecca Hasseli, Anne C Regierer, Anja Strangfeld, et al.
Current Opinion in Rheumatology|February 2, 2018
Rheumatoid arthritis treatment in patients with a history of cancerAnne C Regierer, Anja Strangfeld
Zeitschrift Fur Rheumatologie|July 1, 2021
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]Rebecca Hasseli, Alexander Pfeil, Bimba Franziska Hoyer, et al.
Zeitschrift Fur Rheumatologie|January 2, 2023
[Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version]Katinka Albrecht, Sebastian Binder, Kirsten Minden, et al.
Zeitschrift Fur Rheumatologie|February 7, 2023
Systematic review to estimate the prevalence of inflammatory rheumatic diseases in GermanyKatinka Albrecht, Sebastian Binder, Kirsten Minden, et al.
Rheumatology International|September 9, 2021
A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in GermanyRebecca Hasseli, Alexander Pfeil, Andreas Krause, et al.
Arthritis Research & Therapy|August 2, 2023
Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohortAndreas Reich, Anja Weiß, Lisa Lindner, et al.
RMD Open|September 4, 2020
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRDRebecca Hasseli, Ulf Mueller-Ladner, Tim Schmeiser, et al.
RMD Open|October 21, 2021
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDAnne Constanze Regierer, Rebecca Hasseli, Martin Schäfer, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
Pageof 27